Ten stocks kicked off the trading week with strong gains as investors continued to digest and reposition portfolios ahead of more corporate earnings results.

Meanwhile, Wall Street’s main indices ended mixed, with only the S&P 500 and the tech-heavy Nasdaq finishing in the green, up 0.14 percent and 0.38 percent, respectively. In contrast, the Dow Jones was down by 0.04 percent.

In this article, let us explore this Monday’s 10 biggest gainers and detail the reasons behind their gains.

To compile the list, we focused exclusively on stocks with at least $2 billion in market capitalization and over 5 million shares in trading volume.

10. First Majestic Silver Corp. (NYSE:AG)

First Majestic Silver snapped a five-day losing streak on Monday, adding 4.95 percent to close at $8.69 apiece, as investors resorted to bargain-hunting while digesting the rally in the prices of gold and silver.

During the trading session, spot prices of silver were up by 1.97 percent or 0.75 points at $38.93 per troy ounce, while gold spot prices increased by 1.42 percent or 47.64 points at $3,397.58.

Additionally, First Majestic Silver Corp. (NYSE:AG) saw its share prices drop by 10.68 percent last week after trading lower in the past five consecutive days, making it a prime target for dip buyers.

In recent news, First Majestic Silver Corp. (NYSE:AG) announced the production of 3.7 million ounces of silver in the second quarter of the year, representing a 76-percent increase from the 2.1 million silver ounces in the same period last year. The bulk of the figure, or 1.5 million ounces, was produced at the Los Gatos site alone.

Meanwhile, produced silver equivalent stood at 7.9 million ounces, marking a 48-percent increase from 5.3 million year-on-year.

The impact of the production on its earnings performance is expected to be announced during market hours on August 14.

9. TTM Technologies, Inc. (NASDAQ:TTMI)

TTM Technologies saw its share prices increase by 5.42 percent on Monday to close at $47.47 apiece as market sentiment continued to be fueled by an investment firm’s bullish rating for the company, with investors now repositioning portfolios ahead of its earnings performance.

According to TTM Technologies, Inc. (NASDAQ:TTMI), it will announce the results of its financial and operating performance for the second quarter of the year after market close on July 30, 2025.

In a market note late last week, TTM Technologies, Inc. (NASDAQ:TTMI) earned a higher price target of $50 from investment firm B. Riley, or a 39-percent bump from its previous price target of $36. The latter also gave a “buy” recommendation for the stock.

According to B. Riley, it expects upsides for TTM Technologies, Inc. (NASDAQ:TTMI) amid robust defense budgets alongside continued generative artificial intelligence-driven strength in TTI’s data center and networking verticals.

8. Block, Inc. (NYSE:XYZ)

Block Inc. rallied for a fourth straight day on Monday, adding 7.22 percent to close at $78.08 apiece as investor sentiment was bolstered by its inclusion in the S&P 500 index.

Effective Wednesday, July 23, Block, Inc. (NYSE:XYZ) will begin as a component of the S&P 500 index, replacing energy company Hess Corp. following its $55 billion merger with oil giant Chevron.

Companies added to market indices during the latest rebalancing activities usually pop higher as index-tracking funds are required to add them to their portfolios.

Additionally, getting included in a market index is typically considered a milestone for listed companies as it bolsters their visibility among institutional and retail investors.

Based on its historical earnings reporting dates, Block, Inc. (NYSE:XYZ) will announce the results of its second quarter performance in the first week of August 2025.

According to Block, Inc. (NYSE:XYZ), it expects gross profit for the second quarter of the year to grow by 9.5 percent year-on-year to $2.45 billion.

7. Rocket Companies, Inc. (NYSE:RKT)

Rocket Companies grew its share prices for a fourth day on Monday, adding 7.51 percent to close at $15.04 apiece as investors loaded up positions ahead of the release of its second quarter earnings performance.

In a statement last week, Rocket Companies, Inc. (NYSE:RKT) said it was set to announce its financial and operating highlights for the period on July 31, 2025. A conference call to discuss the results will be held at 4:30 PM Eastern Time.

For the second quarter of the year, Rocket Companies, Inc. (NYSE:RKT) said it expected revenues to settle anywhere between $1.175 billion and $1.325 billion.

In the first quarter, Rocket Companies, Inc. (NYSE:RKT) swung to a net loss of $212 million from a $291 million net income in the same period last year.

Total revenues were also lower by 25 percent to $1.037 billion from $1.384 billion year-on-year.

Investors will be closely watching out for Rocket Companies, Inc.’s (NYSE:RKT) updated outlook for the rest of the year following its successful acquisition of Redfin Corp. and Mr. Cooper Group Inc.

6. Harmony Gold Mining Company Limited (NYSE:HMY)

Harmony Gold snapped a four-day losing streak on Monday, adding 7.53 percent to close at $14.99 apiece as investors took heart from an investment firm’s positive initial coverage and higher price target.

In a market note late last week, BMO Capital gave Harmony Gold Mining Company Limited’s (NYSE:HMY) a “market perform” rating and a price target of $16 apiece, or a 6.7-percent upside from its latest closing price.

According to BMO Capital, its coverage reflected the company’s leadership position in the gold mining industry, adding that it was one of the best performers in the sector.

Additionally, the coverage factored in Harmony Gold Mining Company Limited’s (NYSE:HMY) steady operational results and favorable gold prices.

The investment firm said it would continue to monitor the gold miner’s stock and performance for more visibility on its fiscal 2026 outlook and future capital allocation strategy before assigning a more positive stance on its stock.

5. Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)

Recursion Pharmaceuticals grew its share prices for a fourth straight day on Monday, adding 9.59 percent to close at $6.40 apiece as investors repositioned portfolios ahead of its second quarter earnings results.

Based on its historical reporting dates, Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) will announce the results of its performance in the first week of August 2025.

Investor excitement was further supported by a social media post by the company’s senior director, Peter Ray, about an ongoing drug candidate called REC-3565, which aims to treat relapsed or refractory B-cell lymphomas.

Now on Phase 1 trial, REC-3565 is being developed using Recursion Pharmaceuticals, Inc.’s (NASDAQ:RXRX) advanced AI platform, which is said would not conceive through traditional human design methods.

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the few companies that earned the backing of technology giant Nvidia Corp., one of the key drivers of the Artificial Intelligence sector.

4. SentinelOne, Inc. (NYSE:S)

SentinelOne saw its share prices increase by 9.83 percent on Monday to close at $19.78 apiece following reports that it was mulling over a sale to Palo Alto Networks Inc. (NASDAQ:PANW).

According to the reports, SentinelOne, Inc. (NYSE:S) and Palo Alto Networks Inc. (NASDAQ:PANW) are now in advanced discussions for the potential merger, which could be valued between $8 billion and $10 billion.

Palo Alto, founded by Israeli entrepreneur Nir Zuk, is one of the largest cybersecurity companies globally with a market capitalization of $134 billion.

Both firms have yet to issue their comments about the rumors.

The acquisition reports followed SentinelOne, Inc.’s (NYSE:S) disappointing earnings performance in the first quarter of fiscal year 2026.

According to the company, its net loss nearly tripled to $208 million from $70 million in the same period last year, despite revenues increasing by 23 percent to $229 million from $186 million year-on-year.

Looking ahead, SentinelOne, Inc. (NYSE:S) expects $242 million in revenues for the second quarter of the fiscal year, as well as between $996 million and $1 billion for the full fiscal year.

3. Cleveland-Cliffs Inc. (NYSE:CLF)

Cleveland-Cliffs surged for a fourth straight day on Monday, jumping 12.45 percent to close at $10.66 apiece as investors took heart from an investment firm’s higher price target despite the company’s dismal earnings performance.

In a market note, Citi raised its price target for Cleveland-Cliffs Inc. (NYSE:CLF) by 47 percent to $11 from $7.5 previously, but maintained “neutral” for the stock.

Citi also set a $200-million expectation on Cleveland-Cliffs Inc.’s (NYSE:CLF) adjusted EBITDA for the third quarter of the year, as well as a run-rate annual EBITDA of approximately $1.2 billion.

By next year, Citi expects the company’s EBITDA to further improve to roughly $1.7 billion once the Calvert slab contract concludes.

In the second quarter of the year, Cleveland-Cliffs Inc. (NYSE:CLF) swung to a net loss attributable to shareholders of $483 million from a $9 million net income attributable to stockholders in the same period last year. This put its six-month net loss at $978 million, higher by 1,404 percent from the $65 million in the same period last year.

Revenues for the quarter stood at $4.934 billion, lower by 3.1 percent than the $5.092 billion year-on-year. Revenues for the first semester of the year, however, declined by 7 percent to $9.563 billion from $10.291 billion year-on-year.

2. Astera Labs, Inc. (NASDAQ:ALAB)

Astera Labs rallied for a third straight day on Monday, soaring 19.35 percent to close at $121.89 apiece as investors loaded up positions before the release of its second quarter earnings performance.

According to Astera Labs, Inc. (NASDAQ:ALAB), it will announce the results of its financial and operating highlights after market close on August 5, to be followed by a conference call.

For the second quarter of the year, Astera Labs, Inc. (NASDAQ:ALAB) said it expected revenues to settle within a range of $170 million to $175 million with a gross margin of approximately 74 percent.

Operating expenses are expected to range between $113 million and $115 million, while diluted earnings per share are pegged at $0.10 to $0.11.

The rally reflected strong confidence among investors amid the booming artificial intelligence sector, supported by the US government’s aggressive expansion into the industry.

Astera Labs, Inc. (NASDAQ:ALAB) is a US-based company that supports AI infrastructures through purpose-built connectivity solutions to solve data, network, and memory bottlenecks at a rack scale.

1. Opendoor Technologies Inc. (NASDAQ:OPEN)

Opendoor Technologies soared for a sixth consecutive day on Monday, adding 42.67 percent to close at $3.21 apiece as investors scrambled to push its share price higher amid concerns about potential delisting.

The rally followed a notice from the Nasdaq on May 28 that it failed to maintain its bid price requirement of $1, and that it had 180 days or until November 24 to regain compliance.

Under the rules, the company needs to maintain a $1 bid price for 10 consecutive days to remain a publicly listed company; otherwise, it could face delisting.

Monday’s close marked the fifth straight day for Opendoor Technologies Inc. (NASDAQ:OPEN) to trade above the minimum bid price, having climbed the said level on July 15 after trading below the figure between April 14 and July 14.

Companies typically announce developments that could boost investor confidence or conduct reverse stock split activities to bolster share prices.

READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge fund investor letters by entering your email below.